![](https://investorshub.advfn.com/uicon/496411.png?cb=1505403973)
Thursday, January 04, 2024 8:38:30 AM
To clarify, the NOPAIN Act applies to hospital outpatient services and ambulatory surgical center services only. It applies to Medicare payments only. And it doesn't stop doctors from prescribing pain pills.
As for Pfizer and Merck.... they can strike a deal with the Chinese manufacturer, or with any manufacturer anywhere, and produce the device without banging on BIEL's door. BIEL let the patents expire and then let the two-year reinstatement window close. I don't know for certain that BIEL can't reinstate those patents but it would have been easy during that two-year window and now it will be difficult.
Imagine Merck or Pfizer putting THEIR name on the device. BIEL wouldn't be able to compete. So let's hope Merck and Pfizer don't get interested.
FEATURED ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM